PG17 COST-EFFECTIVENESS ANALYSIS OF TREATING CHORNIC HEPATITITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) PLUS RIBAVIRIN EARLY BEFORE DISEASE PROGRESSES TO MORE ADVANCED STAGE
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65257-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65257-6/fulltext
Title :
PG17 COST-EFFECTIVENESS ANALYSIS OF TREATING CHORNIC HEPATITITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) PLUS RIBAVIRIN EARLY BEFORE DISEASE PROGRESSES TO MORE ADVANCED STAGE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65257-6&doi=10.1016/S1098-3015(10)65257-6
First page :
Section Title :
Open access? :
No
Section Order :
415